Publicaciones en colaboración con investigadores/as de University College London (35)

2024

  1. Albumin reprograms the B cell transcriptional landscape and improves neutrophil antimicrobial function in patients with decompensated cirrhosis

    JHEP Reports, Vol. 6, Núm. 11

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Editorial: Global excellence in rheumatology: Europe

    Frontiers in Medicine

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

    Gastroenterology, Vol. 165, Núm. 3, pp. 696-716

  5. Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages

    Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907

  6. Liver transplantation for patients with severe acute on chronic liver failure: it is time to change paradigms

    Intensive Care Medicine

  7. Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure

    Journal of Hepatology, Vol. 79, Núm. 1, pp. 79-92

  8. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

    Gut, Vol. 72, Núm. 8, pp. 1581-1591

  9. What should a “surviving severe ACLF campaign” look like?

    Intensive Care Medicine

2022

  1. 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

    Annals of the rheumatic diseases, Vol. 81, Núm. 1, pp. 34-40

  2. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  3. Whole-genome sequencing reveals host factors underlying critical COVID-19

    Nature, Vol. 607, Núm. 7917, pp. 97-103

2021

  1. Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation

    Gut, Vol. 70, Núm. 2, pp. 379-387

  2. EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 698-706

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Albumin in decompensated cirrhosis: New concepts and perspectives

    Gut, Vol. 69, Núm. 6, pp. 1127-1138

  2. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF

    Journal of Hepatology, Vol. 72, Núm. 4, pp. 688-701

  3. Correction to ‘Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF’ [J Hepatol 2020 (72) 688–701] (Journal of Hepatology (2020) 72(4) (688–701), (S0168827819306968), (10.1016/j.jhep.2019.11.009))

    Journal of Hepatology

  4. Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations

    RMD open, Vol. 6, Núm. 2